VOI is a publishing and pharmaceutical consulting firm providing clients with global pharmaceutical sales reports and business intelligence.



"Guide to International Pharmaceutical Industry"

NEW 2009 Sixth Edition (Available in Two Volumes)

Order Now and Save...
Pre-Publication Discount price:

Developed Markets - Volume I. $497
Emerging Markets -  Volume II. $422
Volume Set (I and II) $592

ORDER NOW >>
(Order by FAX)

 

VOI Consulting is a life sciences advisory and publishing company dedicated to providing pharmaceutical and biopharmaceutical clients with fact-based analysis and business intelligence to meet market challenges in today’s highly competitive global environment. By skillfully employing innovative research techniques and advanced analytical tools our services help clients minimize risks, cut costs and maximize commercial opportunities.

VOI translates to ”Value of Insight" and plays on the statistical term "Value of Information," which describes the difference between expected outcomes in the absence of information and expected outcomes in the presence of information derived through applied research techniques, sound analysis and experienced judgment. For our clients – including 17 of the top 25 pharmaceutical companies – this insight translates into measurable success.

VOI’s reputation as a leading publisher of pharmaceutical industry reference books and in-depth pharmaceutical market research reports has distinguished the company well beyond the competition as a trusted source of research and analysis.

Our services are global in reach, are relevant for any therapeutic category and span the entire range of the pharmaceutical lifecycle. Whether you are planning a clinical trial or need to assess the market for a generic drug, whether you operate in developed countries or are looking at emerging opportunities in countries like China, India, Russia, Turkey or Latin America, VOI can help you execute better, faster and cheaper. We invite you to contact us today to learn more about how VOI Consulting can be of service.

 

 

 

 

Biosimilars, biogenerics or follow-on biologics

Biosimilars, biogenerics or follow-on biologics – by any name, second generation versions of blockbuster biologic products are coming to America and they are going to have a profound impact on all aspects of the pharmaceutical industry.

ORDER NOW >>

 

 

Now Shipping!

Guide to the Generic Drug Industry

ORDER NOW>>

Learn More>